We are live on ! Find out more
BMY icon

Bristol-Myers Squibb
BMY

1,179 hedge funds and large institutions have $49.8B invested in Bristol-Myers Squibb in 2013 Q2 according to their latest regulatory filings, with 1,179 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.

New
Increased
Maintained
Reduced
Closed

68.53% more ownership

Funds ownership: 0% → 68.53% (+69%)

1% more call options, than puts

Call options by funds: $519M | Put options by funds: $516M

Holders
1,179
Holders Change
+1,179
Holders Change %
–
% of All Funds
38.47%
Holding in Top 10
49
Holding in Top 10 Change
+49
Holding in Top 10 Change %
% of All Funds
1.6%
New
1,179
Increased
–
Reduced
–
Closed
–
Calls
$519M
Puts
$516M
Net Calls
+$2.99M
Net Calls Change
+$2.99M

Top Buyers

No buyers this quarter

Top Sellers

No sellers this quarter
Name Holding Trade Value Shares
Change 		Change in
Stake
FNB
451
First Niagara Bank
New York
$3.37M +$3.28M +75,504 New
GLA
452
Great Lakes Advisors
Illinois
$3.37M +$3.28M +75,448 New
B
453
Bailard
California
$3.35M +$3.26M +75,065 New
EWM
454
Evercore Wealth Management
New York
$3.31M +$3.21M +73,902 New
PAM
455
Paradigm Asset Management
New York
$3.3M +$3.2M +73,800 New
BE
456
Bonness Enterprises
District of Columbia
$3.27M +$3.18M +73,220 New
RJT
457
Raymond James Trust
Florida
$3.26M +$3.17M +72,991 New
PCM
458
Parsons Capital Management
Rhode Island
$3.26M +$3.16M +72,889 New
BFS
459
Bradley Foster & Sargent
Connecticut
$3.23M +$3.14M +72,296 New
AA
460
Ancora Advisors
Ohio
$3.19M +$3.1M +71,392 New
IGIM
461
I.G. Investment Management
Manitoba, Canada
$3.18M +$3.09M +71,238 New
CNBT
462
Canandaigua National Bank & Trust
New York
$3.16M +$3.07M +70,674 New
TP
463
Traxis Partners
Connecticut
$3.13M +$3.04M +70,000 New
CIBC World Market
464
CIBC World Market
Ontario, Canada
$3.11M +$3.03M +69,679 New
HAI
465
Hennessy Advisors Inc
California
$3.11M +$3.02M +69,500 New
BMO
466
Beck Mack & Oliver
New York
$3.09M +$3M +69,216 New
DG
467
Davidson & Garrard
Virginia
$3.08M +$2.99M +68,832 New
MVA
468
Mount Vernon Associates
Maryland
$3.06M +$2.98M +68,593 New
HFM
469
Hartford Financial Management
Connecticut
$3.06M +$2.98M +68,538 New
WB
470
Webster Bank
Connecticut
$3.04M +$2.96M +68,071 New
EAM
471
EULAV Asset Management
Florida
$3.04M +$2.95M +68,000 New
RG
472
Rathbones Group
United Kingdom
$2.98M +$2.9M +66,739 New
First Eagle Investment Management
473
First Eagle Investment Management
New York
$2.97M +$2.89M +66,520 New
CBB
474
Citizens Business Bank
California
$2.95M +$2.87M +66,000 New
FT
475
Fiduciary Trust
Massachusetts
$2.94M +$2.86M +65,872 New
17 18
19
20 21

BMY Hedge Fund Activity: Q2 2013 in Review

1,179 of the 3,065 institutional investors tracked by Wall St. Rank reported a position in Bristol-Myers Squibb (BMY) for Q2 2013, worth a combined $49.8B.

Buyers outnumbered sellers: 1,179 funds opened new BMY positions and 0 closed out — a net gain of 1,179 holders — while 0 added to existing stakes and 0 trimmed.

  • 1,179 institutional investors held Bristol-Myers Squibb (BMY) as of Q2 2013, up from 0 in Q1 2013.
  • Funds reported $49.8B of Bristol-Myers Squibb stock for Q2 2013.
  • 1,179 funds opened new Bristol-Myers Squibb positions in Q2 2013 and 0 closed out, a net change of +1,179 holders.

Based on aggregated 13F filings for Q2 2013.